NCT04961944

HypErsensitiVity PneumonITis: DiseAse Progression Characterization

HypErsensitiVity PneumonITis: DiseAse Progression Characterization. An International Multicentric Prospective Observational Study

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 150 (estimated)
• Sponsor: Hospital do Coracao · Academic / Other
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

EVITA is a multicentric Latin-American prospective cohort on chronic hypersensitivity pneumonitis. EVITA's objective is to identify phenotypes and/or endotypes associated with different disease trajectories measured primarily by forced vital capacity (FVC) during a 24 month follow-up period. Other secondary measures of disease progression will also be investigated such as imaging, time to death or lung transplantation, and patient-reported outcomes

Conditions

• Hypersensitivity Pneumonitis

Interventions

Type	Name	Description
OTHER	Disease assessment	A comprehensive evaluation of the disease's extension, its impact on function, quality of life, and the search for phenotype/endotypes will be performed. The association between endotypes and disease progression will be tested.

Timeline

• Start date: 2022-06-20
• Primary completion: 2025-12-01
• Completion: 2026-03-01
• First posted: 2021-07-14
• Last updated: 2023-06-29

Locations

10 sites across 3 countries: Argentina, Brazil, Chile